Japan struggling with Tamiflu dilemma

Jun 18, 2007

Japanese officials have confirmed hundreds of citizens have displayed abnormal reactions after ingesting the prescription flu medication, Tamiflu.

While initial reports had the total number of citizens afflicted by the medication at 199 in May, Japan's Health, Labor and Welfare Ministry recently confirmed 211 people have now shown symptoms, the Yomiuri Shimbun said Monday.

That figure, which represents reported cases before May 31, was part of an overall total of 1,377 cases that have been recorded since the medication's 2001 release.

Included in that multi-year total are 71 people who died after taking Tamiflu, with some showing abnormal symptoms prior to their deaths and others dying suddenly.

Some experts have theorized the drug, which is produced by the Roche pharmaceutical group in Switzerland, may effectively shut down the nervous systems of those who ingest it.

The newspaper said such a shutdown could potentially result in the abnormal behavior many victims have displayed.

Copyright 2007 by United Press International

Explore further: Added benefit of vedolizumab is not proven

add to favorites email to friend print save as pdf

Related Stories

Sick Alaska seal shows possible spread of disease

Mar 08, 2012

(AP) -- Federal scientists said Wednesday that a nearly bald, lethargic seal recovered from the southeast Alaska coast showed the same symptoms of a disease that sickened ringed seals and Pacific walrus on ...

Seizing the opportunity: treating epilepsy in cats

Sep 02, 2011

Many cat owners are not sure how to react when their animals start behaving abnormally. The diagnosis of epilepsy and similar conditions is particularly difficult because the symptoms are so variable. In some cases the first ...

More accurate diagnosis of Alzheimer's

Apr 19, 2011

A new study from the University of Gothenburg, Sweden, shows how analysing spinal fluid can help to detect Alzheimer's disease at an early stage. The researchers behind the study hope that their findings will contribute to ...

New therapy found for rare lung disorder

Mar 16, 2011

Researchers at the University of Cincinnati (UC) and Cincinnati Children's Hospital Medical Center have found that the FDA-approved drug sirolimus, used primarily to prevent rejection in organ transplant patients, stabilized ...

Recommended for you

Added benefit of vedolizumab is not proven

21 hours ago

Vedolizumab (trade name Entyvio) has been approved since May 2014 for patients with moderately to severely active Crohn disease or ulcerative colitis. In an early benefit assessment pursuant to the Act on the Reform of the ...

Seaweed menace may yield new medicines

Oct 22, 2014

An invasive seaweed clogging up British coasts could be a blessing in disguise. University of Greenwich scientists have won a cash award to turn it into valuable compounds which can lead to new, life-saving drugs.

User comments : 0